speb/financial-data huggingface dataset:
AMSS balance_sheet (annual, 2024-12-31) — Invested Capital: 18037600.00
AMSS cash_flow (annual, 2024-12-31) — Investing Cash Flow: 5112656.00
AMSS balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 5672020.00
AMSS balance_sheet (annual, 2024-12-31) — Investments And Advances: 5672020.00
AMSS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1671456.00
AMSS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 2500000.00
AMSS balance_sheet (annual, 2024-12-31) — Leases: 314518.00
AMSS balance_sheet (annual, 2024-12-31) — Line Of Credit: 3601405.00
AMSS balance_sheet (annual, 2024-12-31) — Long Term Debt: 1814570.00
AMSS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1814570.00
AMSS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 2500000.00
AMSS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2239936.00
AMSS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 348162.00
AMSS balance_sheet (annual, 2024-12-31) — Minority Interest: 4987142.00
AMSS income_statement (annual, 2024-12-31) — Minority Interests: 12838.00
AMSS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
AMSS balance_sheet (annual, 2024-12-31) — Net Debt: 7531927.00
AMSS income_statement (annual, 2024-12-31) — Net Income: -15242690.00
AMSS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -15242690.00
AMSS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -15255528.00
AMSS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -15242690.00
AMSS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -15242690.00
AMSS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -15255528.00
AMSS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -15255528.00
AMSS cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
AMSS income_statement (annual, 2024-12-31) — Net Interest Income: -1688462.00
AMSS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 500000.00
AMSS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -1155508.00
AMSS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 260064.00
AMSS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1688462.00
AMSS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -145138.00
AMSS cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 4625556.00
AMSS balance_sheet (annual, 2024-12-31) — Net PPE: 168179.00
AMSS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -12900.00
AMSS cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 1671456.00
AMSS cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -1415572.00
AMSS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -1958291.00
AMSS balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 13640.00
AMSS income_statement (annual, 2024-12-31) — Normalized EBITDA: -12676242.00
AMSS income_statement (annual, 2024-12-31) — Normalized Income: -15132881.00
AMSS balance_sheet (annual, 2024-12-31) — Notes Receivable: 421653.00
AMSS cash_flow (annual, 2024-12-31) — Operating Cash Flow: -5806377.00
AMSS cash_flow (annual, 2024-12-31) — Operating Gains Losses: 363982.00
AMSS income_statement (annual, 2024-12-31) — Operating Income: -12242954.00
AMSS income_statement (annual, 2024-12-31) — Operating Revenue: 19070546.00
AMSS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 10848077.00
AMSS balance_sheet (annual, 2024-12-31) — Other Current Assets: 558179.00
AMSS balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 2809898.00
AMSS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 57459.00
AMSS income_statement (annual, 2024-12-31) — Other Gand A: 10039494.00
AMSS income_statement (annual, 2024-12-31) — Other Income Expense: -1324112.00
AMSS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 3064240.00
AMSS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1145837.00
AMSS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -1214303.00
AMSS balance_sheet (annual, 2024-12-31) — Payables: 8412794.00
AMSS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 13281603.00
AMSS balance_sheet (annual, 2024-12-31) — Preferred Stock: 216.00
AMSS balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 216.00
AMSS cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 1671456.00
AMSS income_statement (annual, 2024-12-31) — Pretax Income: -15255528.00
AMSS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 79821.00
AMSS balance_sheet (annual, 2024-12-31) — Properties: 0.00
AMSS cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 13992.00
AMSS cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
AMSS cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
AMSS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -12900.00
AMSS balance_sheet (annual, 2024-12-31) — Raw Materials: 2802258.00
AMSS balance_sheet (annual, 2024-12-31) — Receivables: 5031351.00
AMSS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 19581499.00
AMSS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 663492.00
AMSS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2239936.00
AMSS income_statement (annual, 2024-12-31) — Research And Development: 168365.00
AMSS balance_sheet (annual, 2024-12-31) — Retained Earnings: -26127313.00
AMSS cash_flow (annual, 2024-12-31) — Sale Of Investment: 500000.00
AMSS cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
AMSS income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 4122121.00
AMSS income_statement (annual, 2024-12-31) — Selling General And Administration: 14161615.00
AMSS balance_sheet (annual, 2024-12-31) — Share Issued: 10848077.00
AMSS income_statement (annual, 2024-12-31) — Special Income Charges: -322049.00
AMSS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 393382.00
AMSS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 9811943.00
AMSS balance_sheet (annual, 2024-12-31) — Tangible Book Value: -1958507.00
AMSS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AMSS income_statement (annual, 2024-12-31) — Tax Provision: 0.00
AMSS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
AMSS balance_sheet (annual, 2024-12-31) — Total Assets: 39226252.00
AMSS balance_sheet (annual, 2024-12-31) — Total Capitalization: 11626513.00
AMSS balance_sheet (annual, 2024-12-31) — Total Debt: 8225873.00
AMSS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 14799085.00
AMSS income_statement (annual, 2024-12-31) — Total Expenses: 33911479.00
AMSS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 24427167.00
AMSS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 17624073.00
AMSS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1814570.00
AMSS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -12565003.00
AMSS income_statement (annual, 2024-12-31) — Total Unusual Items: -109809.00
AMSS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -109809.00
AMSS cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -212240.00
AMSS balance_sheet (annual, 2024-12-31) — Work In Process: 5417094.00
AMSS balance_sheet (annual, 2024-12-31) — Working Capital: -1010418.00
AMSS income_statement (quarterly, 2025-03-31) — +Operating Expense: 3111507.00
AMSS income_statement (quarterly, 2025-03-31) — +Total Revenue: 4340544.00
AMSS cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: -6615.00
AMSS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 10848077.00
AMSS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.34
AMSS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -22016.00
AMSS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 574227.00
AMSS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -720777.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -401196.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1767955.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Interest Payable: 1986281.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Inventory: 1032963.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -2122.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Payable: -401196.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1366759.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -121239.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 77640.00
AMSS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2354001.00
AMSS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 77640.00
AMSS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3125784.00
AMSS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 150269.00
AMSS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 150269.00
AMSS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 10848077.00
AMSS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.34
AMSS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -3657042.00
AMSS income_statement (quarterly, 2025-03-31) — EBIT: -2175361.00
AMSS income_statement (quarterly, 2025-03-31) — EBITDA: -2025092.00
AMSS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -22016.00
AMSS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -720777.00
AMSS cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 280143.00
AMSS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2118102.00
AMSS income_statement (quarterly, 2025-03-31) — Gross Profit: 1214760.00
AMSS income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
AMSS cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 26408.00
AMSS income_statement (quarterly, 2025-03-31) — Interest Expense: 1544260.00
AMSS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1544260.00
AMSS income_statement (quarterly, 2025-03-31) — Interest Income: 6483.00
AMSS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 6483.00
AMSS cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 1245542.00
AMSS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 574227.00
AMSS cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 945000.00
AMSS cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 945000.00
AMSS cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -61835.00
AMSS income_statement (quarterly, 2025-03-31) — Minority Interests: 62579.00
AMSS income_statement (quarterly, 2025-03-31) — Net Income: -3657042.00
AMSS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -3657042.00
AMSS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -3719621.00
AMSS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -3657042.00
AMSS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3657042.00
AMSS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -3719621.00
AMSS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -3719621.00
AMSS income_statement (quarterly, 2025-03-31) — Net Interest Income: -1537777.00
AMSS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 456882.00
AMSS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 33171.00
AMSS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 883165.00
AMSS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1537777.00
AMSS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -106970.00
AMSS cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 117345.00
AMSS cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -849994.00
AMSS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2025092.00
AMSS income_statement (quarterly, 2025-03-31) — Normalized Income: -3657042.00
AMSS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -720777.00
AMSS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 280143.00
AMSS income_statement (quarterly, 2025-03-31) — Operating Income: -1896747.00
AMSS income_statement (quarterly, 2025-03-31) — Operating Revenue: 4159776.00
AMSS income_statement (quarterly, 2025-03-31) — Other Gand A: 2118102.00
AMSS income_statement (quarterly, 2025-03-31) — Other Income Expense: -285097.00
AMSS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 220911.00
AMSS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -285097.00
AMSS income_statement (quarterly, 2025-03-31) — Pretax Income: -3719621.00
AMSS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 51783.00
AMSS cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -44413.00
AMSS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -43118.00
AMSS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3125784.00
AMSS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 150269.00
AMSS cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -61835.00
AMSS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 500000.00
AMSS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 993405.00
AMSS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3111507.00
AMSS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
AMSS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 44548.00
AMSS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AMSS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
AMSS income_statement (quarterly, 2025-03-31) — Total Expenses: 6237291.00
AMSS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1896747.00
AMSS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
AMSS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
AMSS income_statement (annual, 2025-12-31) — +Operating Expense: 11909324.00
AMSS income_statement (annual, 2025-12-31) — +Total Revenue: 17838534.00
AMSS balance_sheet (annual, 2025-12-31) — Accounts Payable: 8257052.00
AMSS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2317514.00
AMSS balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 68112.00
AMSS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -196919.00
AMSS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 37661354.00
AMSS cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 548241.00
AMSS cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 548241.00
AMSS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 7640909.00
AMSS balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 823746.00
AMSS income_statement (annual, 2025-12-31) — Basic Average Shares: 10848077.00
AMSS income_statement (annual, 2025-12-31) — Basic EPS: -1.34
AMSS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 693946.00
AMSS cash_flow (annual, 2025-12-31) — Capital Expenditure: -17469.00
AMSS balance_sheet (annual, 2025-12-31) — Capital Stock: 250.00
AMSS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 824962.00
AMSS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 824962.00
AMSS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1287175.00
AMSS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 716025.00
AMSS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1869897.00
AMSS cash_flow (annual, 2025-12-31) — Change In Account Payable: -156117.00
AMSS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 666364.00
AMSS cash_flow (annual, 2025-12-31) — Change In Interest Payable: 593871.00
AMSS cash_flow (annual, 2025-12-31) — Change In Inventory: 2868989.00
AMSS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
AMSS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 539353.00
AMSS cash_flow (annual, 2025-12-31) — Change In Payable: -156117.00
AMSS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 510247.00
AMSS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 342506.00
AMSS cash_flow (annual, 2025-12-31) — Change In Receivables: 982000.00
AMSS cash_flow (annual, 2025-12-31) — Change In Working Capital: 5243095.00
AMSS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1050112.00
AMSS cash_flow (annual, 2025-12-31) — Changes In Cash: 133303.00
AMSS balance_sheet (annual, 2025-12-31) — Common Stock: 34.00
AMSS balance_sheet (annual, 2025-12-31) — Common Stock Equity: -2988467.00
AMSS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 735386.00
AMSS income_statement (annual, 2025-12-31) — Cost Of Revenue: 14018658.00
AMSS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 5001077.00
AMSS balance_sheet (annual, 2025-12-31) — Current Assets: 15652197.00
AMSS balance_sheet (annual, 2025-12-31) — Current Debt: 6673602.00
AMSS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6673602.00
AMSS balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 3459044.00
AMSS balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3459044.00
AMSS balance_sheet (annual, 2025-12-31) — Current Liabilities: 23828737.00
AMSS cash_flow (annual, 2025-12-31) — Depreciation: 83108.00
AMSS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 631349.00
AMSS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 631349.00
AMSS balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 520242.00
AMSS income_statement (annual, 2025-12-31) — Diluted Average Shares: 10848077.00
AMSS income_statement (annual, 2025-12-31) — Diluted EPS: -1.34
AMSS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -14577714.00
AMSS balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 1389996.00
AMSS income_statement (annual, 2025-12-31) — EBIT: -14305158.00
AMSS income_statement (annual, 2025-12-31) — EBITDA: -13673809.00
AMSS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -2287.00
AMSS cash_flow (annual, 2025-12-31) — End Cash Position: 824962.00
AMSS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1287175.00
AMSS balance_sheet (annual, 2025-12-31) — Finished Goods: 7215512.00
AMSS cash_flow (annual, 2025-12-31) — Free Cash Flow: -1887366.00
AMSS cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 301301.00
AMSS cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 60743.00
AMSS income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 200970.00
AMSS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 55172.00
AMSS income_statement (annual, 2025-12-31) — General And Administrative Expense: 8734621.00
AMSS balance_sheet (annual, 2025-12-31) — Goodwill: 2972280.00
AMSS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 5174859.00
AMSS balance_sheet (annual, 2025-12-31) — Gross PPE: 209288.00
AMSS income_statement (annual, 2025-12-31) — Gross Profit: 3819876.00
AMSS income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 6064603.00
AMSS cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 15739.00
AMSS income_statement (annual, 2025-12-31) — Interest Expense: 2905969.00
AMSS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2905969.00
AMSS income_statement (annual, 2025-12-31) — Interest Income: 98793.00
AMSS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 98793.00
AMSS cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1018405.00
AMSS balance_sheet (annual, 2025-12-31) — Interest Payable: 694649.00
AMSS balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -3459263.00
AMSS balance_sheet (annual, 2025-12-31) — Inventory: 10873408.00
AMSS balance_sheet (annual, 2025-12-31) — Invested Capital: 4995428.00
AMSS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 716025.00
AMSS balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 823746.00
AMSS balance_sheet (annual, 2025-12-31) — Investments And Advances: 823746.00
AMSS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 735386.00
AMSS cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1359641.00
AMSS balance_sheet (annual, 2025-12-31) — Leases: 95373.00
AMSS balance_sheet (annual, 2025-12-31) — Line Of Credit: 3277034.00
AMSS balance_sheet (annual, 2025-12-31) — Long Term Debt: 1310293.00
AMSS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1310293.00
AMSS cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1359641.00
AMSS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -278012.00
AMSS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 113915.00
AMSS balance_sheet (annual, 2025-12-31) — Minority Interest: 2353729.00
AMSS income_statement (annual, 2025-12-31) — Minority Interests: 2633413.00
AMSS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 735386.00
AMSS balance_sheet (annual, 2025-12-31) — Net Debt: 7158933.00
AMSS income_statement (annual, 2025-12-31) — Net Income: -14577714.00
AMSS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -14577714.00
AMSS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -17211127.00
AMSS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -14577714.00
AMSS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -14577714.00
AMSS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -17211127.00
AMSS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -17211127.00
AMSS cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -17469.00
AMSS income_statement (annual, 2025-12-31) — Net Interest Income: -2807176.00
AMSS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 421537.00
AMSS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 757258.00
AMSS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 1081629.00
AMSS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -2807176.00
AMSS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -275915.00
AMSS cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 299998.00
AMSS balance_sheet (annual, 2025-12-31) — Net PPE: 12369.00
AMSS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 11959.00
AMSS cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
AMSS cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -324371.00
AMSS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -8163110.00
AMSS balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 14015.00
AMSS income_statement (annual, 2025-12-31) — Normalized EBITDA: -7810176.00
AMSS income_statement (annual, 2025-12-31) — Normalized Income: -8714081.00
AMSS balance_sheet (annual, 2025-12-31) — Notes Receivable: 0.00
AMSS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -1869897.00
AMSS cash_flow (annual, 2025-12-31) — Operating Gains Losses: 362044.00
AMSS income_statement (annual, 2025-12-31) — Operating Income: -8089448.00
AMSS income_statement (annual, 2025-12-31) — Operating Revenue: 17467676.00
AMSS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 10848077.00
AMSS balance_sheet (annual, 2025-12-31) — Other Current Assets: 178205.00
AMSS balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 3396568.00
AMSS balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 437962.00
AMSS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 55172.00
AMSS income_statement (annual, 2025-12-31) — Other Gand A: 8734621.00
AMSS income_statement (annual, 2025-12-31) — Other Income Expense: -6314503.00
AMSS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 2202579.00
AMSS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 656609.00
AMSS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 3347564.00
AMSS income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -450870.00
AMSS balance_sheet (annual, 2025-12-31) — Payables: 8257052.00
AMSS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 13258129.00
AMSS balance_sheet (annual, 2025-12-31) — Preferred Stock: 216.00
AMSS balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 216.00
AMSS cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
AMSS income_statement (annual, 2025-12-31) — Pretax Income: -17211127.00
AMSS cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 70446.00
AMSS balance_sheet (annual, 2025-12-31) — Properties: 0.00
AMSS cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -26269.00
AMSS cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -17469.00
AMSS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -78463.00
AMSS cash_flow (annual, 2025-12-31) — Purchase Of PPE: 0.00
AMSS balance_sheet (annual, 2025-12-31) — Raw Materials: 2490029.00
AMSS balance_sheet (annual, 2025-12-31) — Receivables: 3775622.00
AMSS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 14018658.00
AMSS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 631349.00
AMSS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -278012.00
AMSS income_statement (annual, 2025-12-31) — Research And Development: 0.00
AMSS balance_sheet (annual, 2025-12-31) — Retained Earnings: -40705027.00
AMSS cash_flow (annual, 2025-12-31) — Sale Of Investment: 500000.00
AMSS cash_flow (annual, 2025-12-31) — Sale Of PPE: 11959.00
AMSS income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 3174703.00
AMSS income_statement (annual, 2025-12-31) — Selling General And Administration: 11909324.00
AMSS balance_sheet (annual, 2025-12-31) — Share Issued: 10848077.00
AMSS income_statement (annual, 2025-12-31) — Special Income Charges: -6064603.00
AMSS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1034463.00
AMSS balance_sheet (annual, 2025-12-31) — Stockholders Equity: -2988251.00
AMSS balance_sheet (annual, 2025-12-31) — Tangible Book Value: -8163326.00
AMSS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AMSS income_statement (annual, 2025-12-31) — Tax Provision: 0.00
AMSS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
AMSS balance_sheet (annual, 2025-12-31) — Total Assets: 25024750.00
AMSS balance_sheet (annual, 2025-12-31) — Total Capitalization: -1677958.00
AMSS balance_sheet (annual, 2025-12-31) — Total Debt: 7983895.00
AMSS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -634522.00
AMSS income_statement (annual, 2025-12-31) — Total Expenses: 25927982.00
AMSS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 25659272.00
AMSS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 9372553.00
AMSS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1830535.00
AMSS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -14154051.00
AMSS income_statement (annual, 2025-12-31) — Total Unusual Items: -5863633.00
AMSS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -5863633.00
AMSS cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -200970.00
AMSS balance_sheet (annual, 2025-12-31) — Work In Process: 4627130.00
AMSS balance_sheet (annual, 2025-12-31) — Working Capital: -8176540.00
AMSS income_statement (quarterly, 2026-03-31) — +Operating Expense: 3484282.00
AMSS income_statement (quarterly, 2026-03-31) — +Total Revenue: 4149346.00
AMSS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 9588404.00
AMSS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3107561.00
AMSS balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 68112.00
AMSS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -201000.00
AMSS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 39802580.00
AMSS cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: -148985.00
AMSS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 862419.00
AMSS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 14905865.00
AMSS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.28
AMSS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 261.00
AMSS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 991806.00
AMSS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 991806.00
AMSS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 1705119.00
AMSS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 261327.00
AMSS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -1799602.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1331352.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 592704.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Interest Payable: 16348.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Inventory: -807742.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -84040.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Payable: 1331352.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 1924056.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -177867.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Receivables: -807911.00
AMSS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 46496.00
AMSS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -807911.00
AMSS balance_sheet (quarterly, 2026-03-31) — Common Stock: 38.00
AMSS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -5276654.00
AMSS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3076402.00
AMSS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 5666931.00
AMSS balance_sheet (quarterly, 2026-03-31) — Current Assets: 16418321.00
AMSS balance_sheet (quarterly, 2026-03-31) — Current Debt: 5328161.00
AMSS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5328161.00
AMSS balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 3375004.00
AMSS balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 3375004.00
AMSS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 25566205.00
AMSS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 137220.00
AMSS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 137220.00
AMSS balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 530668.00
AMSS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 14905865.00
AMSS income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.28
AMSS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -3035704.00
AMSS balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 0.00
AMSS income_statement (quarterly, 2026-03-31) — EBIT: -2586749.00
AMSS income_statement (quarterly, 2026-03-31) — EBITDA: -2449529.00
AMSS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1705119.00
AMSS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 6461964.00
AMSS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -1799602.00
AMSS cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 59642.00
AMSS income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -49216.00
AMSS balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 55172.00
AMSS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 2516805.00
AMSS balance_sheet (quarterly, 2026-03-31) — Goodwill: 2972280.00
AMSS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 4931319.00
AMSS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 209287.00
AMSS income_statement (quarterly, 2026-03-31) — Gross Profit: 1072944.00
AMSS income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 110402.00
AMSS cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 15739.00
AMSS income_statement (quarterly, 2026-03-31) — Interest Expense: 454856.00
AMSS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 454856.00
AMSS income_statement (quarterly, 2026-03-31) — Interest Income: 3709.00
AMSS income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3709.00
AMSS cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 96830.00
AMSS balance_sheet (quarterly, 2026-03-31) — Interest Payable: 484522.00
AMSS balance_sheet (quarterly, 2026-03-31) — Inventory: 11940537.00
AMSS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2464787.00
AMSS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 261327.00
AMSS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 862419.00
AMSS balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 862419.00
AMSS cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 1351675.00
AMSS balance_sheet (quarterly, 2026-03-31) — Leases: 95372.00
AMSS balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 2928161.00
AMSS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2413280.00
AMSS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2413280.00
AMSS cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 1351675.00
AMSS cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -97854.00
AMSS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 113915.00
AMSS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 2347828.00
AMSS income_statement (quarterly, 2026-03-31) — Minority Interests: 5901.00
AMSS balance_sheet (quarterly, 2026-03-31) — Net Debt: 6749635.00
AMSS income_statement (quarterly, 2026-03-31) — Net Income: -3035704.00
AMSS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -3035704.00
AMSS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -3041605.00
AMSS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -3035704.00
AMSS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3035704.00
AMSS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -3041605.00
AMSS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -3041605.00
AMSS income_statement (quarterly, 2026-03-31) — Net Interest Income: -451147.00
AMSS cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 261327.00
AMSS cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 904948.00
AMSS cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 1253821.00
AMSS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -451147.00
AMSS cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -37315.00
AMSS balance_sheet (quarterly, 2026-03-31) — Net PPE: 8287.00
AMSS cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -348873.00
AMSS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -10207750.00
AMSS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 13640.00
AMSS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2289911.00
AMSS income_statement (quarterly, 2026-03-31) — Normalized Income: -2876086.00
AMSS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -1799602.00
AMSS cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 59642.00
AMSS income_statement (quarterly, 2026-03-31) — Operating Income: -2411338.00
AMSS income_statement (quarterly, 2026-03-31) — Operating Revenue: 3986436.00
AMSS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 14905865.00
AMSS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 310305.00
AMSS balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 2400000.00
AMSS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1607705.00
AMSS balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 55172.00
AMSS income_statement (quarterly, 2026-03-31) — Other Gand A: 2516805.00
AMSS income_statement (quarterly, 2026-03-31) — Other Income Expense: -179120.00
AMSS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1959039.00
AMSS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 908834.00
AMSS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3347564.00
AMSS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -19502.00
AMSS balance_sheet (quarterly, 2026-03-31) — Payables: 9588404.00
AMSS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 15255335.00
AMSS balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 223.00
AMSS balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 223.00
AMSS income_statement (quarterly, 2026-03-31) — Pretax Income: -3041605.00
AMSS cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 837486.00
AMSS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
AMSS cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 17864.00
AMSS cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -38673.00
AMSS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1989007.00
AMSS balance_sheet (quarterly, 2026-03-31) — Receivables: 3175673.00
AMSS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3076402.00
AMSS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 137220.00
AMSS cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -97854.00
AMSS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -43740731.00
AMSS cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 300000.00
AMSS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 967477.00
AMSS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3484282.00
AMSS balance_sheet (quarterly, 2026-03-31) — Share Issued: 14905865.00
AMSS income_statement (quarterly, 2026-03-31) — Special Income Charges: -110402.00
AMSS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 220932.00
AMSS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -5276431.00
AMSS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -10207973.00
AMSS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AMSS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
AMSS balance_sheet (quarterly, 2026-03-31) — Total Assets: 25581550.00
AMSS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -2863151.00
AMSS balance_sheet (quarterly, 2026-03-31) — Total Debt: 7741441.00
AMSS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -2928603.00
AMSS income_statement (quarterly, 2026-03-31) — Total Expenses: 6560684.00
AMSS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 28510153.00
AMSS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 9163229.00
AMSS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2943948.00
AMSS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -2521740.00
AMSS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -159618.00
AMSS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -159618.00
AMSS balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 1393713.00
AMSS balance_sheet (quarterly, 2026-03-31) — Work In Process: 3489566.00
AMSS balance_sheet (quarterly, 2026-03-31) — Working Capital: -9147884.00
AMST cash_flow (annual, 2021-06-30) — Asset Impairment Charge: 0.00
AMST income_statement (annual, 2021-06-30) — Interest Expense: 3613873.00
AMST income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 3613873.00
AMST cash_flow (annual, 2021-06-30) — Issuance Of Debt: 0.00
AMST cash_flow (annual, 2021-06-30) — Net Intangibles Purchase And Sale: -768899.00
AMST cash_flow (annual, 2021-06-30) — Net Issuance Payments Of Debt: 0.00
AMST cash_flow (annual, 2021-06-30) — Net Short Term Debt Issuance: 0.00
AMST cash_flow (annual, 2021-06-30) — Other Non Cash Items: 4623359.00
AMST balance_sheet (annual, 2021-06-30) — Prepaid Assets: 299389.00
AMST cash_flow (annual, 2021-06-30) — Purchase Of Intangibles: -768899.00
AMST cash_flow (annual, 2021-06-30) — Short Term Debt Issuance: 0.00
AMST income_statement (annual, 2022-06-30) — +Operating Expense: 9753519.00
AMST income_statement (annual, 2022-06-30) — +Total Revenue: 697001.00
AMST balance_sheet (annual, 2022-06-30) — Accounts Payable: 122285.00
AMST balance_sheet (annual, 2022-06-30) — Accounts Receivable: 14545.00
AMST balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -66864.00
AMST balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 37412551.00
AMST income_statement (annual, 2022-06-30) — Basic Average Shares: 1939132.00
AMST income_statement (annual, 2022-06-30) — Basic EPS: -4.67
AMST cash_flow (annual, 2022-06-30) — Beginning Cash Position: 10713091.00
AMST cash_flow (annual, 2022-06-30) — Capital Expenditure: -711622.00
AMST cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -695047.00
AMST balance_sheet (annual, 2022-06-30) — Capital Stock: 217.00
AMST balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 7155367.00
AMST balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 7155367.00
AMST cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 3869550.00
AMST cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -711622.00
AMST cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: -6715652.00
AMST cash_flow (annual, 2022-06-30) — Change In Account Payable: 77918.00
AMST cash_flow (annual, 2022-06-30) — Change In Accrued Expense: 14362.00
AMST cash_flow (annual, 2022-06-30) — Change In Other Working Capital: 9472.00
AMST cash_flow (annual, 2022-06-30) — Change In Payable: 77918.00
AMST cash_flow (annual, 2022-06-30) — Change In Payables And Accrued Expense: 92280.00
AMST cash_flow (annual, 2022-06-30) — Change In Prepaid Assets: -260695.00
AMST cash_flow (annual, 2022-06-30) — Change In Receivables: 36575.00
AMST cash_flow (annual, 2022-06-30) — Change In Working Capital: -122368.00
AMST cash_flow (annual, 2022-06-30) — Changes In Account Receivables: 36575.00
AMST cash_flow (annual, 2022-06-30) — Changes In Cash: -3557724.00
AMST balance_sheet (annual, 2022-06-30) — Common Stock: 217.00
AMST balance_sheet (annual, 2022-06-30) — Common Stock Equity: 8135752.00
AMST cash_flow (annual, 2022-06-30) — Common Stock Issuance: 3869550.00
AMST balance_sheet (annual, 2022-06-30) — Current Accrued Expenses: 109095.00
AMST balance_sheet (annual, 2022-06-30) — Current Assets: 7729996.00
AMST balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 342672.00
AMST balance_sheet (annual, 2022-06-30) — Current Deferred Revenue: 342672.00
AMST balance_sheet (annual, 2022-06-30) — Current Liabilities: 748108.00
AMST cash_flow (annual, 2022-06-30) — Depreciation Amortization Depletion: 875604.00
AMST cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 875604.00
AMST income_statement (annual, 2022-06-30) — Diluted Average Shares: 1939132.00
AMST income_statement (annual, 2022-06-30) — Diluted EPS: -4.67
AMST income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: -9059923.00
AMST income_statement (annual, 2022-06-30) — EBIT: -9056518.00
AMST income_statement (annual, 2022-06-30) — EBITDA: -8180914.00
AMST cash_flow (annual, 2022-06-30) — End Cash Position: 7155367.00
AMST cash_flow (annual, 2022-06-30) — Financing Cash Flow: 3869550.00
AMST cash_flow (annual, 2022-06-30) — Free Cash Flow: -7427274.00
AMST income_statement (annual, 2022-06-30) — General And Administrative Expense: 5183863.00
AMST balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 1066674.00
AMST balance_sheet (annual, 2022-06-30) — Gross PPE: 154054.00
AMST income_statement (annual, 2022-06-30) — Interest Expense: 12635.00
AMST income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 12635.00
AMST income_statement (annual, 2022-06-30) — Interest Income: 9230.00
AMST income_statement (annual, 2022-06-30) — Interest Income Non Operating: 9230.00
AMST balance_sheet (annual, 2022-06-30) — Invested Capital: 8135752.00
AMST cash_flow (annual, 2022-06-30) — Investing Cash Flow: -711622.00
AMST cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 3869550.00
AMST balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 154054.00
AMST cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 3869550.00
AMST income_statement (annual, 2022-06-30) — Net Income: -9059923.00
AMST income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -9059923.00
AMST income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -9059923.00
AMST income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -9059923.00
AMST income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -9059923.00
AMST cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: -9059923.00
AMST income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -9059923.00
AMST income_statement (annual, 2022-06-30) — Net Interest Income: 9230.00
AMST income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: 9230.00
AMST balance_sheet (annual, 2022-06-30) — Net PPE: 87190.00
AMST cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -16575.00
AMST balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 7069078.00
AMST income_statement (annual, 2022-06-30) — Normalized EBITDA: -8180914.00
AMST income_statement (annual, 2022-06-30) — Normalized Income: -9059923.00
AMST cash_flow (annual, 2022-06-30) — Operating Cash Flow: -6715652.00
AMST income_statement (annual, 2022-06-30) — Operating Income: -9056518.00
AMST income_statement (annual, 2022-06-30) — Operating Revenue: 697001.00
AMST balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 2166123.00
AMST balance_sheet (annual, 2022-06-30) — Other Current Assets: 560084.00
AMST income_statement (annual, 2022-06-30) — Other Gand A: 5183863.00
AMST income_statement (annual, 2022-06-30) — Other Income Expense: -12635.00
AMST balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 1066674.00
AMST cash_flow (annual, 2022-06-30) — Other Non Cash Items: 148948.00
AMST income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: -12635.00
AMST balance_sheet (annual, 2022-06-30) — Payables: 122285.00
AMST balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 231380.00
AMST balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 174056.00
AMST balance_sheet (annual, 2022-06-30) — Preferred Stock: 0.00
AMST balance_sheet (annual, 2022-06-30) — Prepaid Assets: 560084.00
AMST income_statement (annual, 2022-06-30) — Pretax Income: -9059923.00
AMST cash_flow (annual, 2022-06-30) — Purchase Of PPE: -16575.00
AMST balance_sheet (annual, 2022-06-30) — Receivables: 14545.00
AMST income_statement (annual, 2022-06-30) — Reconciled Depreciation: 875604.00